US OptionsDetailed Quotes
OTLK250117P5000
- 3.18
- 0.000.00%
15min DelayClose Jan 3 16:00 ET
0.00High0.00Low
3.18Open3.18Pre Close0 Volume2 Open Interest5.00Strike Price0.00Turnover484.67%IV18.75%PremiumJan 17, 2025Expiry Date2.76Intrinsic Value100Multiplier12DDays to Expiry0.42Extrinsic Value100Contract SizeAmericanOptions Type-0.6829Delta0.1818Gamma0.74Leverage Ratio-0.0290Theta-0.0012Rho-0.51Eff Leverage0.0014Vega
Outlook Therapeutics Stock Discussion
Sign in to post a comment
$Outlook Therapeutics (OTLK.US)$ Reuters
1 min ago
Outlook Therapeutics Inc - First Positive Reimbursement Decision Worldwide for Lytenava™; First Launch Anticipated in H1 2025
1 min ago
Outlook Therapeutics Inc - First Positive Reimbursement Decision Worldwide for Lytenava™; First Launch Anticipated in H1 2025
6
$Outlook Therapeutics (OTLK.US)$ $3 tonight. A retest at $2.4 yesterday.
4
$Outlook Therapeutics (OTLK.US)$ 👀potential overnight play of today but I don’t like going long in red day
$Outlook Therapeutics (OTLK.US)$
this company very strong support company. until weight January you can get $5
this company very strong support company. until weight January you can get $5
2
1
$Outlook Therapeutics (OTLK.US)$ agen will be come back 5 Dollars
2
1
$Outlook Therapeutics (OTLK.US)$ Next week 2.5-3.0, holding till Jan 2025 where they will release 3 month efficacy report.
3
No comment yet
carlton griffiths OP : despite the losses